Ruxolitinib for the treatment of SARS-CoV-2 induced acute...

  • Main
  • 2020 / 6
  • Ruxolitinib for the treatment of SARS-CoV-2 induced acute...

Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)

Neubauer, Andreas, Wiesmann, Thomas, Vogelmeier, Claus F., Mack, Elisabeth, Skevaki, Chrysanthi, Gaik, Christine, Keller, Christian, Figiel, Jens, Sohlbach, Kristina, Rolfes, Caroline, Renz, Harald, W
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Leukemia
DOI:
10.1038/s41375-020-0907-9
Date:
June, 2020
File:
PDF, 580 KB
2020
Conversion to is in progress
Conversion to is failed